Infinity Pharmaceuticals Story

Requested story not found. it has been either deleted or moved. View all stories for Infinity Pharmaceuticals.

Infinity Pharmaceuticals Latest Timeline

Infinity Pharmaceuticals is listed for 0.04. About 23.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.45. Infinity Pharmaceuticals had not issued any dividends in recent years. The entity had 1:4 split on the 12th of September 2020.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Infinity Pharmaceuticals information on this page should be used as a complementary analysis to other Infinity Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

If you are still planning to invest in Infinity Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Infinity Pharmaceuticals' history and understand the potential risks before investing.